[1] Shiels K,Hawk LW.Self-regulation in ADHD:The role of error processing[J].Clin Psychol Rev,2010,30(8):951-961. [2] Coghill D.The impact of medications on quality of life in Attention-Deficit Hyperactivity Disorder[J].CNS Drug,2010,24(10):843-866. [3] American Psychiatric Association.Diagnostic and statistical manual of mental disorders (4th ed.text rev.)[M].Washington,DC:American Psychiatric Association:2000. [4] 钱英,曲珊,杜巧新,等.Weiss 功能缺陷程度量表父母版的信效度[J].中国心理卫生杂志,2011,25(10):767-771. [5] Santos K,Palmini A,Radziuk AL,et al.The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies[J].Developmental Medicine & Child Neurology,2013,55(7):654-660. [6] Deborah A,Cynthia W,Michael G,et al.Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms[J].Journal Of Child And Adolescent Psychopharmcology,2013,23(5):337-351. [7] Surman CB,Hammerness PG,Pion K,et al.Do stimulants improve functioning in adults with ADHD? A review of the literature[J].Eur Neuropsychopharmacol,2013,23(6):528-533. [8] Hammerness P,Fried R,Petty C,et al.Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD[J].Child Neuropsychology,2014,20(3):319-327. [9] Meftagh SD,Najimi A,Mohammadi N,et al.The most effective intervention for attention deficit hyperactivity disorder:Using continuous performance test[J].Psychiatria Danubina,2014,26(2):165-171. [10] Hwang JW,Kim B,Kim Y,et al.Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder[J].Hum.Psychopharmacol Clin Exp,2013,28(6):600-607. [11] Coghill D.The impact of medications on quality of life in attention-deficit hyperactivity disorder[J].CNS Drug,2010,24(10):843-866. |